Chronic telogen effluvium: potential complication for clinical trials in female androgenetic alopecia?
Rand
S
S
D000328:Adult; D000505:Alopecia / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006197:Hair / Q000254:growth & development / Q000473:pathology*; D018859:Hair Follicle / Q000254:growth & development / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008914:Minoxidil / Q000008:administration & dosage / Q000627:therapeutic use; D018579:Patient Selection; D012107:Research Design
D003879:Dermatologic Agents; D008914:Minoxidil